We stand up for novel and effective drugs

“because we see our patients fighting…”

JHVS Venture Awards 2025 優秀賞受賞のお知らせ

リードファーマ株式会社は、この度、厚生労働省が主催する「ジャパン・ヘルスケアベンチャー・サミット(JHVS)Venture Awards 2025」において、優秀賞を受賞いたしました。私たちは、この栄誉を励みと

Read More »

Founder’s Philosophy

Our company started with a consistent philosophy of our founder, Mariko Harada-Shiba, M.D., Ph.D., a medical doctor and a researcher; “to save patients we see by all means.” We are seeing nucleic acid-based therapeutic drugs as a panacea for various intractable and difficult-to-treat diseases.

Antisense drugs

Proteins are very fundamental and essential components of our bodies, whereas it is a fact that malfunction of them is also involved in many diseases. Protein information is stored in DNA and is extracted as messenger RNA (mRNA) when needed. A nucleic acid drug (called antisense) can bind to this mRNA and suppress the production of disease-related proteins. We believe that this method will lead to the treatment of many diseases for which there have been no effective drugs.

Technologies and
Pipelines

We have succeeded in creating a unique nucleic acid drug discovery platform by utilizing the excellent technologies built at the National Cerebral and Cardiovascular Center, as well as Osaka University, Nagasaki University, Tokushima Bunri University, and others.

Technologies

Pipeline